Skip to content
Thursday 13 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE
MorningWire

European business, markets and politics

FTSE 100
10,772.67
-0.56%
DAX
26,299.74
-0.12%
CAC 40
8,650.56
-0.28%
STOXX 50
6,545.47
+0.18%
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
More
GermanyFranceBankingAIEnergyFintechPropertyCapital Markets
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
  • DE
Sunday 12 December 2021 2:46 pm  |  Updated:  Sunday 12 December 2021 3:10 pm

Omicron “mild” compared to delta, South African doctors say

By: Farah Ghouri

Add as a preferred source on Google
UK Covid Face Mask Rules Tightened Over Omicron Variant Fear
Confusion over Covid rules will only threaten the UK’s economic recovery

Omicron is a mild disease, said Dr Angelique Coetzee of the South African Medical Association in an LBC interview today.

Coetzee, the first South African doctor to alert authorities about patients with the omicron variant, insisted that: “There’s no reason why you can’t trust us when we say to you [Omicron is] a mild disease.”

She acknowledged that there would be some sick patients, but said “it will be the minority”.

Patients “recover within about five days whether you are a child, 80 years of age, whether you’ve been vaccinated or not,” Coetzee explained.

Her comments come as the UK re-enters pandemic restrictions following a wave of Omicron cases. The first people to be hospitalised with Omicron infections have also been reported today by the BBC, according to education secretary Nadhim Zahawi, who has warned that the new Covid-19 variant now accounts for a third of cases in London.

But Coetzee said, based on the experience in South Africa over the last four weeks, “there’s no need to hospitalise any of these mild cases. There’s really no need.”

“The severity of the disease is not delta. It is mild disease,” she said of the new Covid-19 variant, which was first detected by researchers in Southern Africa at the end of November.

“Our ICUs are not full. Our public sector hospitals have seen an increase but they don’t have a lot of beds.”

South Africa’s National Institute for Communicable Diseases confirmed that only around 30 per cent of people hospitalised with Covid in recent weeks have been seriously ill – less than half the rate compared to the first weeks of previous waves of the pandemic.

Read more

Alkermes’ Alixorexton Demonstrated Sustained Improvement in Wakefulness in Adults With Narcolepsy Type 1 and Type 2 in Long-Term Extension Study Interim Analysis

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business

Related Topics

  • Coronavirus

Trending Articles

  • Five-star Mayfair hotel hit with HMRC winding-up petition

  • Revolut takes flight with launch of new airport lounges

  • It’s not just Jason Arday, most of sociology is a scam

  • IT consultant ordered to pay £50,000 after being accused of stealing Soho House members’ personal details

  • Grandparents fund university degrees to avoid inheritance tax net

More from Morning Wire

  • Alkermes’ Alixorexton Demonstrated Sustained Improvement in Wakefulness in Adults With Narcolepsy Type 1 and Type 2 in Long-Term Extension Study Interim Analysis

    Business Wire
  • Motsepe backed to succeed Fifa’s Infantino by South African minister

    Sport Business
    GettyImages 2282672294 depicts a significant event related to the articles context, showcasing key elements and atmosphere.
  • Almirall Announces EMA Acceptance for Filing of Paediatric Registration of Ebglyss (Lebrikizumab) in Atopic Dermatitis in Children 6 Months and Older

    Business Wire
  • Dompé Doses First Patient in Phase 3 Study of Cenegermin-bkbj in NAION

    Business Wire
  • Silence Therapeutics Announces Positive Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera, Supporting its Potential Best-in-Class Profile

    Business Wire
  • VoxNeuro Receives FDA 510(k) Clearance for Cognitive Function Neuroimaging (cfNI) Software – An Objective EEG/ERP Brain Health Assessment

    Business Wire
  • Verdiva Bio Initiates Phase 1 Study of VRB-103, a Selective Oral Amylin Peptide Analog With Weekly Dosing Potential

    Business Wire
  • Prothena Reports Second Quarter 2026 Financial Results and Business Highlights

    Business Wire
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Business

  • Markets
  • Banking
  • Technology
  • Energy
  • Property
  • Fintech

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook